三叶草生物-B(02197):三叶草香港收到全球疫苗免疫联盟针对三叶草香港提交的仲裁请求

智通财经
Jun 09, 2025

智通财经APP讯,三叶草生物-B(02197)发布公告,三叶草香港于2025年6月6日收到全球疫苗免疫联盟针对三叶草香港提交的仲裁请求,要求退还预付款金额(该诉求)。与该等公告所述一致,公司基于《预购协议》的条款认为该诉求缺乏依据,并将全力以赴、严正有力地维护自身权益。

集团将继续致力于推进其自研专有的呼吸道合胞病毒(RSV)候选疫苗SCB-1019在RSV疫苗重复接种和作为相关呼吸道联合疫苗一部分的研究应用开发。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10